The linkage of FMRP values and the expression of metabotropic glutamate receptors subtype 5 (mGluR5) in the living human brain could provide a tool to ameliorate cognitive and behavioral symptoms associated with FXS such as ASD [2,6,7,41,42]. This evidence concerns the gene GRM5 and fragile X syndrome.